Skip to main content
Clinical Trials/JPRN-UMIN000006215
JPRN-UMIN000006215
Completed
未知

A study of the changes of biomarkers for various types of tobacco in healthy adult male smokers - A biomarker study for various types of tobacco

JAPAN TOBACCO INC.0 sites120 target enrollmentDecember 31, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
JAPAN TOBACCO INC.
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 31, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who have regular use experience of hand\-rolled cigarette, cigarillo, cigar, pipe, smokeless tobacco or chewing tobacco 2\. Subjects who donate 200ml or more of blood within 4 weeks before screening, or who donate 400ml or more of blood within 12 weeks before screening (including blood donation) or subjects who donate plasma or platelet within 4 weeks before screening etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Brain Connectivity in Neurodevelopmental Disorders in Response to TreatmentAutism Spectrum DisordersPsychosisFragile X Syndrome
NCT01364818University of North Carolina, Chapel Hill25
Unknown
Not Applicable
A Retrospective Study of Biomarkers in Non-Small Cell Lung CancerNon Small Cell Lung Cancer
NCT01100840National University Hospital, Singapore
Recruiting
Not Applicable
BIOMarker PILOT study to identify the Acute risk of a Coronary Syndrome (BIOMArCS PILOT)” and Hartinfarct-biomarker onderzoek (deel I)” .1. Acute coronary syndromes<br /> 2. unstable angina pectoris<br /> 3. non ST-elevation myocardial infarction<br /> 4. ST-elevation myocardial infarction<br /> 5. coronary artery disease<br /> 6. biomarkers<br /> 7. atherosclerosis<br />(Nederlands: acuut coronaire syndromen, instabiele angina pectoris, non ST-elevatie hartinfarct, ST-elevatie hartinfarct, coronaire vaatziekten, biomarkers, atherosclerose).
NL-OMON29278Initiator / Lead Principal Investigator:H. Boersma, PhD, MSc. Erasmus Medical Center (EMC), Department of Cardiology, section Clinical Epidemiology. Postaddress: P.O. Box 2040, 3000 CA RotterdamAddress: 's-Gravendijkwal 230 Postalcode: 3015 CE City: RotterdamCountry: Netherlands Telephone: +31 10 4632307 Fax: +31 10 4089484E-mail: h.boersma@erasmusmc.nl100
Completed
Not Applicable
Study of the relation between biomarker patterns and the incidence of recurrent coronary events during 1-year follow-up in patients who were hospitalised for an acute coronary syndrome; BIOMarker Study to identify the Acute risk of a Coronary Syndrome (BIOMArCS)coronary artery disease'furring' of the coronary arteries1001108210003216
NL-OMON43706Erasmus MC, Universitair Medisch Centrum Rotterdam900
Completed
Phase 4
Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.Heart Failure
NCT02887183Novartis Pharmaceuticals794